Dimitri Drekonja, MD, MS - Minneapolis VA Health Care System
Attention A T users. To access the menus on this page please perform the following steps. 1. Please switch auto forms mode to off. 2. Hit enter to expand a main menu option (Health, Benefits, etc). 3. To enter and activate the submenu links, hit the down arrow. You will now be able to tab or arrow up or down through the submenu options to access/activate the submenu links.

Minneapolis VA Health Care System

Menu
Menu
Veterans Crisis Line Badge
My HealtheVet badge
EBenefits Badge
 

Dimitri Drekonja, MD, MS

Dimitri Drekonja

Staff Physician, Minneapolis VA Health Care System

Chair, IRB-A Committee, Minneapolis VA Health Care System

Telephone: 612-467-4183

Email: Dimitri.drekonja@va.gov





Education

  • BA, Gustavus Adolphus College, St Peter, MN
  • MS, University of Minnesota, Minneapolis, MN
  • MD, University of Minnesota, Minneapolis, MN

Research Interests

  • Leading clinical trial of treatment duration for male urinary tract infections
  • Co-leading clinical trial of fecal microbiota therapy for recurrent C. difficile infection
  • Antimicrobial stewardship and appropriate antimicrobial prescribing

Selected Publications

  • Drekonja DM, Reich J, Gezahegn S, Greer N, Shaukat A, MacDonald R, Rutks I, Wilt TJ. Fecal Microbiota Transplantation for Clostridium difficile Infection – A Systematic Review. Ann Intern Med. 2015 May 5;162(9):630-8. PMID: 25938992
  • Eccles-Radtke C, Rector TS, Cutting A, Drekonja DM. Urinary tract infections in male veterans with HIV. Open Forum Inf Dis. 2014 Nov 5;1(3). PMID: 25734168
  • Drekonja DM, Gnadt C, Kuskowski MA, Johnson JR. Urine cultures among hospitalized veterans: casting too broad a net? Infect Control Hosp Epidemiol. 2014 May;35(5):574-6. PMID: 24709728
  • Drekonja DM, Beekman SE, Elliott S, Mukundan D, Polenakovik H, Rosenthal ME, et al. Challenges in the management of infections due to carbapenem-resistant Enterobacteriaceae. Infect Control Hosp Epidemiol. 2014 Apr;35(4):437-9. PMID: 24602953
  • Shaughnessy MK, Amundson WH, Kuskowski MA, DeCarolis DD, Johnson JR, Drekonja DM. Unnecessary antimicrobial use in patients with current or recent Clostridium difficile infection. Infect Control Hosp Epidemiol. 2013, Feb;34(2):109-16. PMID: 23295554
  • Drekonja DM, Rector T, Cutting A, Johnson JR. Urinary tract infection in male veterans: treatment patterns and outcomes. Arch Intern Med. 2013 Jan;173(1):62-8. PMID: 23212273
  • Drekonja DM, Butler M, MacDonald R, Bliss D, Filice GA, Rector TS, Wilt TJ. comparative effectiveness of Clostridium difficile treatments: a systematic review. Ann Intern Med. 2011 Dec 20;155(12):839-47. PMID: 22184691
  • Drekonja DM, Amundson WH, DeCarolis DD, Kuskowski MA, Lederle FA, Johnson JR. Antimicrobial use and risk for recurrent Clostridium difficile infection. Am J Med. 2011 Nov. 124(11):1081.e1-7. Epub 2011 Sep 22. PMID: 21944159

 

Back